These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 8931674)

  • 1. Phase II study of docetaxel in advanced soft tissue sarcomas.
    Edmonson JH; Ebbert LP; Nascimento AG; Jung SH; McGaw H; Gerstner JB
    Am J Clin Oncol; 1996 Dec; 19(6):574-6. PubMed ID: 8931674
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phase II study with docetaxel (Taxotere) in advanced soft tissue sarcomas of the adult. EORTC Soft Tissue and Bone Sarcoma Group.
    van Hoesel QG; Verweij J; Catimel G; Clavel M; Kerbrat P; van Oosterom AT; Kerger J; Tursz T; van Glabbeke M; van Pottelsberghe C
    Ann Oncol; 1994 Jul; 5(6):539-42. PubMed ID: 7918126
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Phase II study of docetaxel in patients with advanced stage soft tissue sarcoma].
    Amodio A; Carpano S; Paoletti G; Gionfra T; Rinaldi M; Manfredi C; Foggi P; Lopez M
    Clin Ter; 1998; 149(2):121-5. PubMed ID: 9780476
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combination docetaxel/cyclophosphamide in patients with advanced solid tumors.
    Valero V
    Oncology (Williston Park); 1997 Aug; 11(8 Suppl 8):34-6. PubMed ID: 9364540
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [A late phase II clinical study of RP56976 (docetaxel) in patients with advanced or recurrent gastric cancer: a cooperative study group trial (group B)].
    Mai M; Sakata Y; Kanamaru R; Kurihara M; Suminaga M; Ota J; Hirabayashi N; Taguchi T; Furue H
    Gan To Kagaku Ryoho; 1999 Mar; 26(4):487-96. PubMed ID: 10097745
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phase II and pharmacologic study of docetaxel as initial chemotherapy for metastatic breast cancer.
    Hudis CA; Seidman AD; Crown JP; Balmaceda C; Freilich R; Gilewski TA; Hakes TB; Currie V; Lebwohl DE; Baselga J; Raptis G; Gollub M; Robles M; Bruno R; Norton L
    J Clin Oncol; 1996 Jan; 14(1):58-65. PubMed ID: 8558221
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A late phase II study of RP56976 (docetaxel) in patients with advanced or recurrent breast cancer.
    Adachi I; Watanabe T; Takashima S; Narabayashi M; Horikoshi N; Aoyama H; Taguchi T
    Br J Cancer; 1996 Jan; 73(2):210-6. PubMed ID: 8546908
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [An early phase II clinical study of RP56976 (docetaxel) in patients with breast cancer].
    Taguchi T; Hirata K; Kunii Y; Tabei T; Suwa T; Kitajima M; Adachi I; Tominaga T; Shimada H; Sano M
    Gan To Kagaku Ryoho; 1994 Oct; 21(14):2453-60. PubMed ID: 7944491
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [An early phase II clinical study of RP56976 (docetaxel) in patients with cancer of the gastrointestinal tract].
    Taguchi T
    Gan To Kagaku Ryoho; 1994 Oct; 21(14):2431-7. PubMed ID: 7944488
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Phase I clinical trial of RP 56976 (docetaxel) a new anticancer drug].
    Taguchi T; Furue H; Niitani H; Ishitani K; Kanamaru R; Hasegawa K; Ariyoshi Y; Noda K; Furuse K; Fukuoka M
    Gan To Kagaku Ryoho; 1994 Sep; 21(12):1997-2005. PubMed ID: 7916183
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Docetaxel: an interesting new drug for the treatment of head and neck cancers and soft tissue sarcomas.
    Verweij J
    Anticancer Drugs; 1995 Jul; 6 Suppl 4():19-24. PubMed ID: 8745350
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Phase II clinical study of RP56976 (docetaxel) in patients with carcinoma ovarii or carcinoma colli uteri].
    Noda K; Terajima Y; Ogita Y; Kono I; Hirabayashi K; Yakushiji M; Taguchi T
    Gan To Kagaku Ryoho; 1994 Oct; 21(14):2471-7. PubMed ID: 7944493
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Late phase II clinical study of RP56976 (docetaxel) in patients with advanced/recurrent gastric cancer: a Japanese Cooperative Study Group trial (group A)].
    Taguchi T; Sakata Y; Kanamaru R; Kurihara M; Suminaga M; Ota J; Hirabayashi N
    Gan To Kagaku Ryoho; 1998 Oct; 25(12):1915-24. PubMed ID: 9797814
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Late phase II clinical study of RP56976 (docetaxel) in patients with advanced/recurrent breast cancer].
    Taguchi T; Mori S; Abe R; Hasegawa K; Morishita Y; Tabei T; Sasaki Y; Fujita M; Enomoto K; Hamano K
    Gan To Kagaku Ryoho; 1994 Nov; 21(15):2625-32. PubMed ID: 7979423
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Randomized phase II study of docetaxel versus doxorubicin in first- and second-line chemotherapy for locally advanced or metastatic soft tissue sarcomas in adults: a study of the european organization for research and treatment of cancer soft tissue and bone sarcoma group.
    Verweij J; Lee SM; Ruka W; Buesa J; Coleman R; van Hoessel R; Seynaeve C; di Paola ED; van Glabbeke M; Tonelli D; Judson IR
    J Clin Oncol; 2000 May; 18(10):2081-6. PubMed ID: 10811673
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Late phase II trial of RP56976 (Docetaxel) in patients with non-small-cell lung cancer].
    Onoshi T; Watanabe K; Furuse K; Kurita Y; Sugiura T; Sato K; Fujii M; Oizumi K; Abe S; Inoue Y
    Gan To Kagaku Ryoho; 1995 Jan; 22(1):59-65. PubMed ID: 7826079
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Docetaxel is a major cytotoxic drug for the treatment of advanced breast cancer: a phase II trial of the Clinical Screening Cooperative Group of the European Organization for Research and Treatment of Cancer.
    Chevallier B; Fumoleau P; Kerbrat P; Dieras V; Roche H; Krakowski I; Azli N; Bayssas M; Lentz MA; Van Glabbeke M
    J Clin Oncol; 1995 Feb; 13(2):314-22. PubMed ID: 7844592
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A multicentre phase II study of the efficacy and safety of docetaxel as first-line treatment of advanced breast cancer: report of the Clinical Screening Group of the EORTC.
    Fumoleau P; Chevallier B; Kerbrat P; Krakowski Y; Misset JL; Maugard-Louboutin C; Dieras V; Azli N; Bougon N; Riva A; Roche H
    Ann Oncol; 1996 Feb; 7(2):165-71. PubMed ID: 8777173
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A phase II study of single-agent docetaxel chemotherapy for non-small cell lung cancer.
    Perng RP; Shih JF; Chen YM; Chou KC; Lee YC; Tsai CM
    Jpn J Clin Oncol; 2000 Oct; 30(10):429-34. PubMed ID: 11185888
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Docetaxel: an active drug for squamous cell carcinoma of the head and neck.
    Dreyfuss AI; Clark JR; Norris CM; Rossi RM; Lucarini JW; Busse PM; Poulin MD; Thornhill L; Costello R; Posner MR
    J Clin Oncol; 1996 May; 14(5):1672-8. PubMed ID: 8622087
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.